Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 60687-390

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 60687-390). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Metoprolol Succinate 100 mg Blister Card (100 mg Metoprolol Succinate Er Tablet Blister)

Metoprolol Succinate 100 mg extended-release oral tablets packaging label from American Health Packaging. The label includes the drug name, dosage strength, dosage form, and a barcode with lot and expiry date placeholders. The label design is repeated multiple times on the sheet.*

FDA Label Image

100 mg Metoprolol Succinate Er Tablets Carton

Metoprolol Succinate 100 mg extended-release oral tablets by American Health Packaging. The label indicates a bottle containing 100 film-coated tablets in a 10 by 10 count format, for prescription use only. The label includes dosage strength, NDC 60687-413-01, usage instructions, storage conditions, and manufacturer details.*

FDA Label Image

Metoprolol Succinate 25 mg Blister Card (25 mg Metoprolol Succinate Er Tablet Blister)

Labels for Metoprolol Succinate Extended-Release Tablets USP, 25 mg, film-coated extended-release oral tablets. Each label includes product name, strength, barcode, lot and expiration placeholders, and American Health Packaging as the labeler located in Columbus, Ohio. Labels are arranged in two columns with multiple repeats.*

FDA Label Image

25 mg Metoprolol Succinate Er Tablets Carton

The image shows a label for Metoprolol Succinate Extended-Release Tablets USP, 25 mg strength. The film-coated tablets are in a pack of 100 (10 x 10). The label includes dosage form, quantity, and a barcode. It also notes the labeler as American Health Packaging, based in Columbus, Ohio.*

FDA Label Image

Metoprolol Succinate 50 mg Blister Card (50 mg Metoprolol Succinate Er Tablet Blister)

Metoprolol Succinate 50 mg extended-release film-coated tablets label from American Health Packaging. The label includes the dosage form, strength, and barcode, along with lot and expiration date fields and the manufacturer name and address in Columbus, Ohio.*

FDA Label Image

50 mg Metoprolol Succinate Er Tablets Carton

Label for Metoprolol Succinate extended-release tablets USP, 50 mg strength, oral dosage form. The label indicates a package of 100 tablets (10 x 10) and is marked Rx Only. It includes dosage details and storage instructions. The product is packaged and distributed by American Health Packaging, Columbus, Ohio.*

FDA Label Image

Drr04660

Metoprolol Succinate 25 mg tablet, round, white, film-coated, extended-release oral tablet. One side is embossed with an 'M' above a score line and the number '3' below. The other side is plain. This form matches the 25 mg strength of Metoprolol Succinate by American Health Packaging.*

FDA Label Image

Drr04661

Metoprolol Succinate 25 mg extended-release film-coated tablet, white, oval-shaped with scored line on one side. One side is marked with 'M' on the left and '1' on the right of the score.*

FDA Label Image

Drr04670

Metoprolol Succinate 50 mg film-coated extended-release tablet. The round, white tablet is imprinted with an "M" above a score line and the number "2" below it on one side; the other side is plain. Manufactured by American Health Packaging for oral use.*

FDA Label Image

Figure (Figure)

A forest plot chart titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. It compares metoprolol succinate extended-release tablets versus placebo across various patient subgroups such as geographic location, NYHA class, ejection fraction, etiology, sex, race, myocardial infarction history, diabetes, hypertension, and heart rate.*

FDA Label Image

Structure (Structure)

Chemical structure of metoprolol succinate showing the molecular arrangement of atoms including aromatic rings, hydroxyl groups, and carboxylic acid moieties, consistent with the active ingredient metoprolol succinate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.